Covestor’s Delcath Systems DCTH Stock Holding History

Covestor’s Portfolio DCTH Stock Details DCTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14K	Buy	1,099 +115	+12%	+$1.27K	0.01%	1326
2026 Q1	$9K	Buy	+984	New	+$9.53K	0.01%	1460

Other funds holding DCTH

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Algert Global San Francisco, California $8.43B AUM 80.94% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Covestor's DCTH Position: Q2 2026 in Review

Covestor increased its Delcath Systems (DCTH) stake by 12% in Q2 2026, buying an estimated $1.27K and bringing the position to 1,099 shares worth $14K. The position accounts for 0.01% of the portfolio, ranked #1326.

Covestor first reported a position in DCTH in Q1 2026 and has held it in 2 quarters since. 119 funds tracked by Wall St. Rank hold DCTH as of Q2 2026.

Covestor held 1,099 shares of Delcath Systems worth $14K as of Q2 2026.
Covestor bought 115 Delcath Systems shares in Q2 2026, an estimated $1.27K.
Delcath Systems made up 0.01% of Covestor's portfolio in Q2 2026, its #1326 holding.
Covestor first reported a position in Delcath Systems in Q1 2026 and has held it in 2 quarters since.
119 funds tracked by Wall St. Rank held Delcath Systems as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.